Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
A quadrigeminal cistern arachnoid cyst is an extremely rare cause of trigeminal neuralgia in adulthood. This report presents the fourth case in the literature of trigeminal neuralgia caused by a giant quadrigeminal cistern arachnoid cyst. A 52-year-old woman presented with a 3-month history of cerebellar ataxia and vertigo. She had a 2-year history of trigeminal neuralgia that was unresponsive to medical therapy. Neuroimaging studies revealed a cystic lesion in the quadrigeminal cistern associated with hydrocephalic enlargement. Using an infratentorial supracerebellar approach, neuroendoscope-assisted decompression and fenestration of the cyst were performed. Postoperatively, the patient was pain-free and able to walk unaided without symptoms of ataxia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.14744/agri.2023.70845 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Autologous Fibrin Glue in Microvascular Decompression for Trigeminal Neuralgia and Hemifacial Spasm.
Neurol Med Chir (Tokyo)
September 2025
Department of Neurosurgery, Tokyo Medical University.
Adhesive materials are widely used in microvascular decompression for treating neurovascular compression syndromes. They play an important role in the critical step of vessel fixation. Recently, completely autologous fibrin glue produced solely from a patient's own plasma was developed.
View Article and Find Full Text PDFTrigeminal microvascular decompression for medically refractory Short-lasting Unilateral Neuralgiform Headache Attacks: a single-centre retrospective analysis.
World Neurosurg
September 2025
Headache and Facial Pain Service, Guy's and St Thomas' NHS Foundation Trust, London, UK; Wolfson SPaRC, Institute of Psychiatry, Psychology & Neuroscience, King's College London. Electronic address:
Objective: This analysis aims to evaluate the sustained effectiveness of trigeminal microvascular decompression (MVD) in patients with medically refractory Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA) who demonstrate trigeminal neurovascular conflict (NVC) ipsilateral to the painful side.
Methods: This is a retrospective single-centre analysis of prospectively collected data conducted between September 2012 and March 2025 to investigate the efficacy and safety of trigeminal MVD in consecutive refractory chronic SUNHA patients suitable for surgery. All patients underwent a magnetic resonance imaging (MRI) with specific trigeminal sequences before surgery.
Introduction: Neurovascular compression (NVC) often drives trigeminal neuralgia (TGN) pathology. This study examines the incidence, diagnostic accuracy, and role of NVC.
Methods: We conducted a retrospective review of patients ≥18 years with medically refractory TGN who underwent MRI, plus a secondary cohort of medically responsive patients.
Adjunctive 810 nm photobiomodulation with pharmacotherapy for trigeminal neuralgia: A randomized controlled trial in a tertiary care centre.
J Photochem Photobiol B
August 2025
Unit of Oral Medicine and Radiology, Faculty of Dental Sciences, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India.
Background: Trigeminal neuralgia (TN) is a debilitating orofacial pain disorder. Pharmacotherapy with carbamazepine is the mainstay of treatment, but adverse effects and tolerance often limit its long-term use. Low-level laser therapy (LLLT) has shown promise in managing various neuropathic pains, yet no study has assessed its efficacy as an adjunct in TN treatment within an Indian population.
View Article and Find Full Text PDFBridging the Beam Gap: Expanding Global Access to Stereotactic Radiosurgery Through Policy and Innovation.
Cureus
August 2025
Neurosurgery-Gamma Knife Program, International Cancer Center, Diagnostic Hospital, San Salvador, SLV.
Stereotactic radiosurgery (SRS), a noninvasive technique that delivers a high dose of ionizing radiation to a precisely defined focal target volume, is foundational to modern neuro-oncology and functional neurosurgery. SRS provides highly accurate, noninvasive treatment for a range of intracranial conditions, including malignant and benign tumors, vascular malformations such as arteriovenous malformations (AVMs), and movement or functional disorders like trigeminal neuralgia. Despite a well-documented safety record and demonstrable efficacy, significant disparities in accessibility persist across global, geographic, and socioeconomic lines.
View Article and Find Full Text PDF